“…Our previous studies have shown that adult mice exposed to this frequency range (20–25 kHz) exhibited depressive-like and anxiety-like behaviors, in addition to physiological, hormonal and molecular changes, including neuroinflammation and oxidative stress ( Strekalova et al, 2018 ; Gorlova et al, 2019 , 2023 ; Pavlov et al, 2019 , 2023 ; Sambon et al, 2020 ; de Munter et al, 2021 ). More specifically, exposure to artificially generated ultrasound (20–25 kHz) in male mice was associated with upregulated corticosterone levels ( Pavlov et al, 2019 ), activated hippocampal microglia, upregulated IL-1β and IL-6 production locally in the hippocampus and within the systemic circulation ( Costa-Nunes et al, 2020 ; de Munter et al, 2021 ; Pavlov et al, 2023 ), and increased content of protein carbonyl in limbic structures, which is a marker of oxidative stress ( Gorlova et al, 2019 ; Sambon et al, 2020 ). Notably, ultrasound (US)-exposed male mice developed prominent depressive-like and anxiety-like behavioral changes ( Strekalova et al, 2018 ; Sambon et al, 2020 ; de Munter et al, 2021 ) that were counteracted by long-term administration of the classic antidepressant fluoxetine ( Morozova et al, 2016 ) and by treatments with antioxidants ( Sambon et al, 2020 ; Costa-Nunes et al, 2020 ; de Munter et al, 2021 ).Thus, US provides a closer analogy to human emotional stressors and recapitulates the key features of MDD and their pharmacological sensitivity in adult rodents.…”